Literature DB >> 26523259

Reversible Cerebral Vasoconstriction Syndrome and Posterior Reversible Encephalopathy Syndrome Presenting with Deep Intracerebral Hemorrhage in Young Women.

Won Jae Lee1, Je Young Yeon1, Kyung-Il Jo1, Jong-Soo Kim1, Seung-Chyul Hong1.   

Abstract

Reversible cerebral vasoconstriction syndrome (RCVS) is a group of syndromes characterized by reversible segmental constriction of cerebral arteries. Posterior reversible encephalopathy syndrome (PRES) is another clinical-radiologic syndrome characterized by reversible, posterior-predominant brain edema. Although the exact causes of these reversible syndromes are poorly understood, these entities may share some common pathophysiologic elements leading to hemorrhagic strokes and rarely, deep intracerebral hemorrhage (ICH). Recent studies have suggested that endothelial dysfunction is a common pathophysiologic factor associated with these syndromes. We report on two young female patients who presented with deep ICH and were later diagnosed as RCVS and PRES. Both patients suffered from vasoconstriction and delayed ischemic stroke. Early detection of distinguishing clinical-radiologic features associated with these reversible syndromes and removing triggers would facilitate successful treatment with no complications.

Entities:  

Keywords:  Cerebral arteries; Cerebral hemorrhage; Cerebral vasospasm; Posterior reversible encephalopathy syndrome (PRES)

Year:  2015        PMID: 26523259      PMCID: PMC4626349          DOI: 10.7461/jcen.2015.17.3.239

Source DB:  PubMed          Journal:  J Cerebrovasc Endovasc Neurosurg        ISSN: 2234-8565


  19 in total

1.  Multimodal imaging of reversible cerebral vasoconstriction syndrome: a series of 6 cases.

Authors:  C P Marder; M M Donohue; J R Weinstein; K R Fink
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-15       Impact factor: 3.825

Review 2.  Narrative review: reversible cerebral vasoconstriction syndromes.

Authors:  Leonard H Calabrese; David W Dodick; Todd J Schwedt; Aneesh B Singhal
Journal:  Ann Intern Med       Date:  2007-01-02       Impact factor: 25.391

Review 3.  Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-10       Impact factor: 3.825

4.  Endothelial dysfunction and hypertension.

Authors:  Ralf P Brandes
Journal:  Hypertension       Date:  2014-08-25       Impact factor: 10.190

5.  Posterior reversible encephalopathy syndrome: the endothelial hypotheses.

Authors:  A Marra; M Vargas; P Striano; L Del Guercio; P Buonanno; G Servillo
Journal:  Med Hypotheses       Date:  2014-03-01       Impact factor: 1.538

Review 6.  Reversible cerebral vasoconstriction syndrome.

Authors:  Anne Ducros
Journal:  Lancet Neurol       Date:  2012-10       Impact factor: 44.182

7.  Imaging pattern of intracranial hemorrhage in the setting of posterior reversible encephalopathy syndrome.

Authors:  Aseem Sharma; Ryan T Whitesell; Kelsey J Moran
Journal:  Neuroradiology       Date:  2009-12-03       Impact factor: 2.804

8.  Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features.

Authors:  H M Hefzy; W S Bartynski; J F Boardman; D Lacomis
Journal:  AJNR Am J Neuroradiol       Date:  2009-04-22       Impact factor: 3.825

9.  The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients.

Authors:  Anne Ducros; Monique Boukobza; Raphaël Porcher; Mariana Sarov; Dominique Valade; Marie-Germaine Bousser
Journal:  Brain       Date:  2007-11-19       Impact factor: 13.501

10.  Reversible cerebral vasoconstriction syndrome after blood transfusion.

Authors:  Yi-Hsuan Dou; Jong-Ling Fuh; Shih-Pin Chen; Shuu-Jiun Wang
Journal:  Headache       Date:  2014-03-13       Impact factor: 5.887

View more
  7 in total

1.  Reversible cerebral vasoconstriction syndrome and posterior reversible encephalopathy syndrome associated with intracranial hypotension.

Authors:  Katharina Feil; Robert Forbrig; Franziska S Thaler; Julian Conrad; Suzette Heck; Franziska Dorn; Hans-Walter Pfister; Andreas Straube
Journal:  Neurocrit Care       Date:  2017-02       Impact factor: 3.210

2.  Simvastatin improves intracerebral hemorrhage through NF-κB-mediated apoptosis via the MyD88/TRIF signaling pathway.

Authors:  Chengyao Gu; Yunqin Wu; Zhenyi Fan; Weiwei Han
Journal:  Exp Ther Med       Date:  2017-10-23       Impact factor: 2.447

3.  An unusual case of posterior reversible encephalopathy syndrome in a patient being weaned from intrathecal morphine.

Authors:  Jasper Van Aalst; Onno P Teernstra; Wim E Weber; Kim Rijkers
Journal:  Int Med Case Rep J       Date:  2016-05-17

4.  Anti-inflammatory effects of Simvastatin in patients with acute intracerebral hemorrhage in an intensive care unit.

Authors:  Xiurong Zhou; Jiafeng Chen; Chengdong Wang; Lili Wu
Journal:  Exp Ther Med       Date:  2017-10-16       Impact factor: 2.447

5.  Clinical characteristics of hypertensive encephalopathy in pediatric patients.

Authors:  Chang Hoon Ahn; Seung-A Han; Young Hwa Kong; Sun Jun Kim
Journal:  Korean J Pediatr       Date:  2017-08-14

6.  Early Fluid Attenuation Inversion Recovery Sulcal Contrast Enhancement Correlates with Severity of Reversible Cerebral Vasoconstriction Syndrome.

Authors:  Ze'ev Itsekson-Hayosh; Galia Tsarfati; Gahl Greenberg; Michal Sharon; Mati Bakon; Anton Wohl; Joab Chapman; David Orion
Journal:  J Stroke       Date:  2020-09-29       Impact factor: 6.967

7.  Posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome associated spinal subdural hematoma: A case report.

Authors:  Hanfeng Chen; Ziqi Xu; Yuan Yuan
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.